BiotechTube
Home/NeuroTrigger/Michal Marks
MM

Michal Marks

COO

NeuroTrigger

Therapeutic Areas

Muscle RehabilitationNeurologyPhysical Therapy

NeuroTrigger Pipeline

DrugIndicationPhase
NTB Muscle StimulatorMuscle re‑education, disuse atrophy preventionCommercial
Eye Closure StimulationFacial paralysis rehabilitationPreclinical

Leadership Team at NeuroTrigger

DN
Dr. Nikolai Kunicher
CEO
PE
Prof. Eyal Gur
Medical Director
DA
Dr. Assaf Deutsch
Co‑Founder, R&D Director
SP
Shachar Paz
Co‑Founder
DH
Dr. Hagit Deutsch
Co‑Founder
SA
Shalom Auerbach
Director
DB
Dr. Barak Azmon
Director
View full NeuroTrigger profile